Literature DB >> 6164720

Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells.

R C Schwartz, G E Sonenshein, A Bothwell, M L Gefter.   

Abstract

The murine plasmacytoma MOPC 315, which synthesizes a complete IgA molecule containing lambda 2 light chains, is shown to synthesize a polypeptide related to the lambda 1 light chain. The abnormal lambda 1 polypeptide (m.w. approximately equal to 18,000) is encoded by a shorter polyA+ mRNA than the lambda 1 mRNAs of lambda 1-producing plasmacytomas. Polypeptides containing lambda 1-specific antigenic determinants have been found to be synthesized both in vitro by translations of RNA and in intact cells. HOPC-1, a lambda 1-producing plasmacytoma, was found to synthesize, in addition to the normal lambda 1-encoding mRNA, a lambda 2 RNA of normal length. A lambda 2-producing hybridoma does not appear to synthesize RNA encoding lambda 1 sequences. The results presented here show that more than 1 light chain gene may be transcribed within a single plasmacytoma cell. Although more than 1 light chain gene may be transcribed, the product of only 1 gene appears to be utilized for the synthesis of complete immunoglobulin molecules. This suggests novel mechanisms for the control of immunoglobulin expression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164720

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Induction of murine CD5 expression by v-H-ras.

Authors:  T R Weichert; R C Schwartz
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells.

Authors:  R C Schwartz; L W Stanton; S C Riley; K B Marcu; O N Witte
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

4.  Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.

Authors:  J B Konopka; S Clark; J McLaughlin; M Nitta; Y Kato; A Strife; B Clarkson; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.

Authors:  A M Mes-Masson; J McLaughlin; G Q Daley; M Paskind; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Authors:  E S Kawasaki; S S Clark; M Y Coyne; S D Smith; R Champlin; O N Witte; F P McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line.

Authors:  J D Bretz; S C Williams; M Baer; P F Johnson; R C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  The role of I-J and Igh determinants on F1-derived suppressor factor in controlling restriction specificity.

Authors:  M Minami; I Aoki; N Honji; C R Waltenbaugh; M E Dorf
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.